AstraZeneca Plc (AZN) led declines among American depositary receipts of European companies after the drug maker rejected Pfizer Inc.’s (PFE) sweetened takeover offer. The Bank of New York Mellon Europe ADR Index fell 0.6%, while the S&P 500 Stock Index gained 0.3%. AstraZeneca fell 11% to $71.33 per ADR after rebuffing Pfizer’sRead More
Post Tagged with: "Mechel OAO"
Mechel OAO (MTL) American depositary shares declined Monday, after the mining-and-steel giant named Andrey Slivchenko as its new chief financial officer. Slivchenko will succeed Stanislav Ploschenko, who is leaving Mechel after seven years for a new job that wasn’t specified. Slivchenko is a former CEO of OJSC Pharmacy Chain 36.6. BeforeRead More